Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Common Stock Will Begin Trading on a Split-Adjusted Basis on October 28, 2025Enveric Biosciences (NASDAQ:ENVB) ("Enveric...
EB-003, Enveric's lead product candidate, is protected by a different patent family that includes an issued U.S. patent and...
Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generati...
https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-sugge...
https://www.marijuanamoment.net/new-york-lawmakers-hold-hearing-psilocybins-medical-benefits-amid-broader-debate-over-psychedel...
Key CMC achievements advance EB-003 on the path to first-in-human trials
